Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag vs IVIG for perioperative management of thrombocytopenia in ITP
2016-004295-22Phase 4Active
- Sponsor
- HagaZiekenhuis
- Start
- Jan 2017
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in immune thrombocytopenia (ITP) and Thrombocytopenia comparing Eltrombopag arm with IVIG arm (2 arms). Primary endpoint: Proportion of patients achieving target platelet count pre-surgery and maintaining target range perioperatively. Started Jan 2017; status: active.
02
Drugs
eltrombopagHuman normal immunoglobulin G
03
Conditions
immune thrombocytopenia (ITP)Thrombocytopenia
Beyond the preview
Go deeper on 2016-004295-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004295-22.